May 25 |
Brokers Are Upgrading Their Views On Alvotech (NASDAQ:ALVO) With These New Forecasts
|
May 23 |
Alvotech First Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.24 loss in 1Q 2023)
|
May 22 |
Alvotech (ALVO) Q1 2024 Earnings Call Transcript
|
May 22 |
Alvotech 2024 Q1 - Results - Earnings Call Presentation
|
May 21 |
Stocks Hold Steady On Mixed Fed Remarks, First Solar Rallies, Bitcoin Falls Below $70,000: What's Driving Markets Tuesday?
|
May 13 |
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
|
May 2 |
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
|
Apr 30 |
Alvotech to produce Humira biosimilar for Cigna's Quallent
|
Apr 30 |
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
|
Apr 25 |
Alvotech: Consider Buying As Positive Q1 Earnings Release Likely
|